At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 22 enrolled
Drug / intervention
Lorazepam 1 mg IM +3 moredrug
Likely dose
Lorazepam 1 mg IMfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ADASUVE®-Lorazepam Drug-Drug Interaction Study
In Brief
A Phase 4 clinical trial evaluating Lorazepam 1 mg IM, Inhaled loxapine 10 mg, and 2 other interventions for Healthy Volunteers. Completed, enrolled 22 participants across 1 site.
Detailed Summary
This study will compare the safety and effects over time for giving both ADASUVE and lorazepam (intramuscular) compared to that of each agent given alone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJun 2013
First PostedJun 2013
Primary CompletionJul 2013
TodayJul 2026
First PostedJun 14, 2013
Enrollment StartJun 1, 2013
Primary CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 13.0 years ago
Interventions
Lorazepam 1 mg IMdrug
Lorazepam 1 mg intramuscular
Inhaled loxapine 10 mgdrug
Inhaled Staccato loxapine 10 mg
Inhaled Placebodrug
Inhaler with no drug in it to mimic the ADASUVE inhaler
Placebo IMdrug
intramuscular placebo to mimic lorazepam 1 mg IM